AAA
ASTX

Alpine Associates Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Alpine Associates Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,719,600
Closed -$14.6M – 103
2013
Q3 		$14.6M Buy
+1,719,600
New +$10.9M 0.59% 45

Alpine Associates Advisors's ASTX Position: Q4 2013 in Review

Alpine Associates Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 1,719,600 shares — an estimated $14.6M sold.

Alpine Associates Advisors first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $14.6M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Alpine Associates Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Alpine Associates Advisors sold 1,719,600 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $14.6M.
  • Alpine Associates Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Alpine Associates Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $14.6M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Alpine Associates Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.